Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06571110 · ClinicalTrials.gov registry record · NA

Analgesic Response to Opioids in Patients With Fibromyalgia After Conventional Acupuncture Versus Sham Acupuncture

A NA study of Fibromyalgia, sponsored by University of California, Irvine.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT06571110 is a NA study of Fibromyalgia that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 45 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06571110, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

This study aims to see whether acupuncture can help fibromyalgia patients by giving them acupuncture treatment and seeing whether acupuncture helps enhance the effects of an opioid.

Conditions Studied

Interventions

  • PROCEDURE Traditional Acupuncture
  • PROCEDURE Sham Acupuncture

Study Locations (1)

California

  • UCI Health Susan Samueli Integrative Health Institute - Irvine

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2025-03-15
Est. Completion 2026-12-01
Phase NA

Sponsor

University of California, Irvine

368 total trials

What the Registry Record Tells You About NCT06571110

The ClinicalTrials.gov registry entry for NCT06571110 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (75% lower). The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Traditional Acupuncture is the first listed.

NCT06571110 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06571110 about?

NCT06571110 is a clinical study titled "Analgesic Response to Opioids in Patients With Fibromyalgia After Conventional Acupuncture Versus Sham Acupuncture". This study aims to see whether acupuncture can help fibromyalgia patients by giving them acupuncture treatment and seeing whether acupuncture helps enhance the effects of an opioid.

What is the current status of trial NCT06571110?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-03-15. Estimated completion is 2026-12-01.

What conditions does trial NCT06571110 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT06571110?

The interventions under investigation include: Traditional Acupuncture (PROCEDURE), Sham Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT06571110?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06571110 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.